The rate of transition from an unstable to a stable complex and the dependence of this on the number of fatty acid ligands present was determined for the binding of warfarin on human serum albumin. When oleate or palmitate was added in amounts up to 2:1 excess to human serum albumin Solutions the measured rate constant for the transition (k 2 ) was increased in comparison with fatty acid free albumin. When the fatty acid concentration is further increased, k 2 decreases. When the fatty acid level is 2 to 3 mol per mol albumin, the affinity constant (K A ) is higher than for fatty acid free Solutions. With higher ratios the value for K A is reduced. According to the observed changes in kinetic parameters, the binding of warfarin is apparently affected allosterically. A reduced plasma protein binding of coumarins should be expected when fatty acid levels are raised over a prolonged period.
free fatty acid undergo specific binding, whereasuc on molecules associate unspecifically. Although the j Human serum albumin has several binding sites for warfarin binding site is located separately, the warfaj endogenous and exogenpus substances. The warfarin rin binding process is dependent on the degree of l binding site (l -5) and the indole or benzodiazepine Saturation of the albumin molecule by free fatty acids binding site (2, (4) (5) (6) (7) (8) iüteraet specifically with these (16, 22) . Thus, a study of the kinetics of the warfarinligands. Other specific binding sites for bilirubin (9, albumin binding process should provide Information 10), digitoxin (4, (11) (12) (13) (14) and for long-chain fatty on interaction mechanisms -whether competitive acids (15) (16) (17) (18) (19) (20) have been suggested. According to the or allosteric -between these two dififerent classes of binding studies by Goodman (21) two molecules of binding sites on albumin.
Materials and Methods
A solution of fatty acid-free human albumin was prepared by dissolving crystalline albumin (Sigma, St. Louis, USA) in double distilled water. The fatty acid content of this solution using the method of Duncombe (23) was 0.03 m'ol per mol albumin. The concentration of albumin was determined by UVspectroscopy using the absorbance value A2eonm= 5.3 for solutions of 10 g/l albumin in water at pH = 7.4 and T = 298 K. Solutions used for the measurements were obtained by dilution with 0.066 mol/1 Sörensen phosphate bufier.
Concentration of warfarin (3-acetonylbenzyl-4-hydroxycoumarin) dissolved in Sörensen bufier was determined photometrically using the molar lineic absorbance 8 310mm = 1.76 · l O 3 m 2 /mol.
Solid sodium palmitate and sodium oleate (Sigma) were dissolved in albumin Solutions by stirring and the concentration determined using the method of Duncombe (23) .
Kinetics of warfarin binding were studied in a Durrum-Gibson stopped-fiow apparatus (22, 24) . The complexation reaction was followed from the time course of fluorescence development. Excitation energy was generated by a Xenon-high-pressure lamp (150 Watt) with a maximum at 380 nm. Emission radiation was monitored at 324 nm with sharp cut filtering for scattered lightof wavelength greaterthan 360 nm. Fluorescence Signals were displayed on an oscillograph and stored on floppy discs. 
T7=T^k-' (H)
Rearrangement leads to a linear relationship between experimental and calculated constants:
Results

Effect of variable palmitate concentrations on the kinetics of warfarin binding on human serum albumin
The iiifluence of sodium pahnjftate on the rate of warfarin complexation was studied using a human serum albumin concentration in the ränge 0.03 · l O" 4 mol/1 to 1.09 · 10~4 mol/1 and a warfarin concentration of 0.025 · 10~4 mol/1 or 0.05 -10~4 mol/1. Typical fluorescence Signals are shown in figure l, and k re i values, obtained by iterative calculation, are listed in table l a. Velocity constants k2 (associative process) and k_ 2 (dissociative process) cornbined with affinity constants K^ and K A (tab. 2 a) show evidence for a relationship between warfarm binding on albumin and free fatty acid ligandation. Binding velocity is enhanced by raising the molar concentration ratiö to 2 mol palmitate per mol albumin. Relaxation constants therefore increase, büt on raising the concentration further to more than 3 mol palmitate per mol albumin, they decrease. The velocity constant k 2 is maximal in the presence of 2 mol free fatty acid per mol albumin with k2 = 171. Rictbrock, Menke, Reuter, Laßmann and Schmeidl: Influence of palmitate and oleate on warfarin binding to albumin
Discussion
The kinetics of the specific warfarin human serum albumin binding process is clearly dependent on the concentration of free fatty acids. The enhancement of the warfarin interactions at its specific binding site is evidently caused by an allostefic effect since the binding sites for the two ligands seem to be located apart from one another. The rate of rearrangement, described by the velocity constant k 2 , is increased when 2 to 3 mol free fatty acid per mol albumin occupy their binding sites. According to the kinetic Parameters the rearrangement from the primary unstable complex W-HSA' into the stable complex W-. HSA appears to be the rate limiting Step (tab. 2 a and 2 b). Presumably warfarin, in its deprotonated form, is bound to several amino-acid side chains in the active cleft. Conformational changes in albumin to produce the stable bound state are facilitated when the 2 specific fatty acid binding sites are occupied. This is reflected in the binding constant K A , and a competitive interaction between the different ligands can be excluded.
The results obtained for saturated and unsaturated fatty acids were similar and thus side-chain stereochemistry is not a determinant factor in this phenomenon. The affinity constants derived from the kinetic Parameters agree well with data of Wüding et al. (16) measured directly using equilibrium dialysis. These authors obtained maximal values for K A when the oleate or palmitate to albumin molar ratio was 3.
The extent of this agreement would of course be dependent on the assumption that the reaction model on which calculation of kinetic parameters was based faithfully reflects the events of the binding and interaction process. The effects of fatty acids on the rate constant k 2 , which are maximal at a molar ratio of approximately 2, is in accord with the known existence of 2 binding sites for free fatty acids on human serum albumin. In contrast, the binding constant K A is influenced to some extent by variations in K A , the pre-equilibrium cpnstant. Binding constants for these three dfugs were of the same order (26) indicating that binding seems to be maintained essentially by the cpumarin-ring. Thus, the coiiclusion from our investigation with warfarin may be extrapolated to phenprocoumon and acecoumarol.
A decrease or increase of coumarin protein binding could have an effect on the pharmacological activity of anticoagulant drugs. Short-term rises in fatty acid levels however do not influence the Inhibition of blood clotting because of the long half-life time of clotting factors (27) . On the other band, diseases producing long-term increases in fatty acid levels, e. g. diabetes mellitus (28) and hyperthyreosis (29) or prolonged extended heparin therapy may cause an unwanted enhancement in drug action, in particular where hepatic coumarin-clearance remains constant.
